Long non-coding RNA MEG3 silencing weakens high glucose-induced mesangial cell injury by decreasing LIN28B expression by sponging and sequestering miR-23c

다국어 초록 (Multilingual Abstract)

Background: Diabetic nephropathy (DN) is a common kidney disease in diabetic patients. Long non-coding RNA maternally expressed gene 3 (MEG3) and microRNA (miR)-23c are reported to be implicated in DN development. Nevertheless, it is unclear that the molecular mechanism between MEG3 and miR-23c in DN remains unclear. Methods: Human mesangial cells (HMCs) were treated with high glucose (HG) to simulate the DN status in vitro. Expression of MEG3 and miR-23c was measured. Effects of MEG3 silencing on HG-stimulated HMC injury were determined. The relationship between MEG3 and miR-23c was verified by the dual-luciferase reporter and RNA immunoprecipitation assays. Results: MEG3 was overexpressed in serums from DN patients and HG-stimulated HMCs. MEG3 knockdown weakened HG-stimulated HMC proliferation, extracellular matrix (ECM) accumulation, and inflammation. MEG3 regulated lin-28 homolog B (LIN28B) expression through adsorbing miR-23c. MiR-23c inhibitor reversed MEG3 knockdown-mediated effects on HG-stimulated HMC proliferation, ECM accumulation, and inflammation. LIN28B overexpression overturned miR-23c mimic-mediated effects on HG-stimulated HMC proliferation, ECM accumulation, and inflammation. Conclusion: MEG3 regulated HMC injury via regulation of the miR-23c/LIN28B axis in DN, which can help us better understand the mechanism of DN mediated by MEG3.

참고문헌 (Reference)

• 1 Fu X, "miR-152/LIN28B axis modulates high-glucose-induced angiogenesis in human retinal endothelial cells via VEGF signaling" 121 : 954-962, 2020
• 2 Chen B, "circLRP6 regulates high glucose-induced proliferation, oxidative stress, ECM accumulation, and inflammation in mesangial cells" 234 : 21249-21259, 2019
• 3 Gao P, "Yin Yang 1 protein ameliorates diabetic nephropathy pathology through transcriptional repression of TGFβ1" 11 : eaaw2050-, 2019
• 4 Umanath K, "Update on diabetic nephropathy : core curriculum 2018" 71 : 884-895, 2018
• 5 Carew RM, "The role of EMT in renal fibrosis" 347 : 103-116, 2012
• 6 Dong-Wei Liu ; Jia-Hui Zhang ; Feng-Xun Liu ; Xu-Tong Wang ; Shao-Kang Pan ; Deng-Ke Jiang ; Zi-Hao Zhao ; Zhang-Suo Liu, "Silencing of long noncoding RNA PVT1 inhibits podocyte damage and apoptosis in diabetic nephropathy by upregulating FOXA1" 51 : 1-15, 2019
• 7 Gonzalez DM, "Signaling mechanisms of the epithelial-mesenchymal transition" 7 : re8-, 2014
• 8 Li Y, "Roles of identified long noncoding RNA in diabetic nephropathy" 2019 : 5383010-, 2019
• 9 Park JT, "Repression of let-7 by transforming growth factor-β1-induced Lin28 upregulates collagen expression in glomerular mesangial cells under diabetic conditions" 307 : F1390-F1403, 2014
• 10 Wolf G, "New insights into the pathophysiology of diabetic nephropathy : from haemodynamics to molecular pathology" 34 : 785-796, 2004
• 11 Mendell JT, "MicroRNAs in stress signaling and human disease" 148 : 1172-1187, 2012
• 12 Bartel DP, "MicroRNAs : genomics, biogenesis, mechanism, and function" 116 : 281-297, 2004
• 13 Li N, "MicroRNA 379 5p suppresses renal fibrosis by regulating the LIN28/let 7 axis in diabetic nephropathy" 44 : 1619-1628, 2019
• 14 Wu J, "MiR-455-3p suppresses renal fibrosis through repression of ROCK2 expression in diabetic nephropathy" 503 : 977-983, 2018
• 15 Xu J, "Metformin inhibits high glucose-induced mesangial cell proliferation, inflammation and ECM expression through the SIRT1-FOXO1-autophagy axis" 46 : 813-820, 2019
• 16 Bhattacharjee N, "Mechanistic insight of diabetic nephropathy and its pharmacotherapeutic targets : an update" 791 : 8-24, 2016
• 17 Ghafouri-Fard S, "Maternally expressed gene 3(MEG3) : a tumor suppressor long non coding RNA" 118 : 109129-, 2019
• 18 Li X, "Long noncoding RNA MALAT1 regulates renal tubular epithelial pyroptosis by modulated miR-23c targeting of ELAVL1 in diabetic nephropathy" 350 : 327-335, 2017
• 19 Shi X, "Long non-coding RNAs : a new frontier in the study of human diseases" 339 : 159-166, 2013
• 20 Zha F, "Long non-coding RNA MEG3 promotes fibrosis and inflammatory response in diabetic nephropathy via miR-181a/Egr-1/TLR4 axis" 11 : 3716-3730, 2019
• 21 Li J, "Long non-coding RNA MEG3 impacts diabetic nephropathy progression through sponging miR-145" 11 : 6691-6698, 2019
• 22 Gao J, "LncRNA-NR_033515 promotes proliferation, fibrogenesis and epithelial-to-mesenchymal transition by targeting miR-743b-5p in diabetic nephropathy" 106 : 543-552, 2018
• 23 Li N, "LncRNA NEAT1 accelerates the occurrence and development of diabetic nephropathy by sponging miR-23c" 24 : 1325-1337, 2020
• 24 Shihabudeen Haider Ali MS, "LncRNA Meg3 protects endothelial function by regulating the DNA damage response" 47 : 1505-1522, 2019
• 25 Li G, "LncRNA MEG3 inhibits rheumatoid arthritis through miR-141 and inactivation of AKT/mTOR signalling pathway" 23 : 7116-7120, 2019
• 26 Zhang L, "LncRNA KTN1-AS1 promotes tumor growth of hepatocellular carcinoma by targeting miR-23c/ERBB2IP axis" 109 : 1140-1147, 2019
• 27 Li A, "LincRNA 1700020I14Rik alleviates cell proliferation and fibrosis in diabetic nephropathy via miR-34a-5p/Sirt1/HIF-1α signaling" 9 : 461-, 2018
• 28 Lu M, "LINC01410/miR-23c/CHD7 functions as a ceRNA network to affect the prognosis of patients with endometrial cancer and strengthen the malignant properties of endometrial cancer cells" 469 : 9-19, 2020
• 29 Zhang J, "LIN28 regulates stem cell metabolism and conversion to primed pluripotency" 19 : 66-80, 2016
• 30 Loganathan TS, "Interactions among non-coding RNAs in diabetic nephropathy" 11 : 191-, 2020
• 31 Kim D, "Inhibition of ChREBP ubiquitination via the ROS/Akt-dependent downregulation of Smurf2 contributes to lysophosphatidic acid-induced fibrosis in renal mesangial cells" 29 : 31-, 2022
• 32 Miyoshi N, "Identification of an imprinted gene, Meg3/Gtl2 and its human homologue MEG3, first mapped on mouse distal chromosome 12 and human chromosome 14q" 5 : 211-220, 2000
• 33 Huang H, "Gremlin induces cell proliferation and extra cellular matrix accumulation in mouse mesangial cells exposed to high glucose via the ERK1/2 pathway" 14 : 33-, 2013
• 34 Thiery JP, "Epithelial-mesenchymal transitions in development and disease" 139 : 871-890, 2009
• 35 Magee C, "Diabetic nephropathy : a tangled web to unweave" 31 : 579-592, 2017
• 36 Qiao S, "Bergenin impedes the generation of extracellular matrix in glomerular mesangial cells and ameliorates diabetic nephropathy in mice by inhibiting oxidative stress via the mTOR/β-TrcP/Nrf2 pathway" 145 : 118-135, 2019
• 37 Salmena L, "A ceRNA hypothesis : the Rosetta Stone of a hidden RNA language?" 146 : 353-358, 2011
• 38 Guo W, "A LIN28B tumor-specific transcript in cancer" 22 : 2016-2025, 2018